Search Results - "Vakrakou, A. G."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders by Zografou, C., Vakrakou, A. G., Stathopoulos, P.

    Published in Frontiers in immunology (17-06-2021)
    “…As B cells differentiate into antibody-secreting cells (ASCs), short-lived plasmablasts (SLPBs) are produced by a primary extrafollicular response, followed by…”
    Get full text
    Journal Article
  2. 2

    Heterogeneity of Baló's concentric sclerosis: a study of eight cases with different therapeutic concepts by Tzanetakos, D, Vakrakou, A G, Tzartos, J S, Velonakis, G, Evangelopoulos, M E, Anagnostouli, M, Koutsis, G, Dardiotis, E, Karavasilis, E, Toulas, P, Stefanis, L, Kilidireas, C

    Published in BMC neurology (02-11-2020)
    “…Baló's Concentric Sclerosis (BCS) is a rare heterogeneous demyelinating disease with a variety of phenotypes on Magnetic Resonance Imaging (MRI). Existing…”
    Get full text
    Journal Article
  3. 3

    A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes by Vakrakou, A G, Tzanetakos, D, Valsami, S, Grigoriou, E, Psarra, K, Tzartos, J, Anagnostouli, M, Andreadou, E, Evangelopoulos, M E, Koutsis, G, Chrysovitsanou, C, Gialafos, E, Dimitrakopoulos, A, Stefanis, L, Kilidireas, C

    Published in BMC neurology (29-10-2018)
    “…Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to…”
    Get full text
    Journal Article